sciencebriefs
13:00in productionCh. 1 · Heat, cool, copy, repeat/ 13:00 · ceiling 15 min
Genetics · Medicine

Polymerase chain reaction

Thirty cycles of heating and cooling turn one strand of DNA into roughly a billion copies. The method came from Kary Mullis in 1983 and won a Nobel Prize; his later claims about HIV and AIDS did not come from the same place and should not borrow its authority.

The polymerase chain reaction amplifies a chosen stretch of DNA by cycling a sample through heating and cooling steps that separate the strands, attach short primers, and let a heat-stable enzyme copy the sequence, doubling it each round. Conceived by Kary Mullis at Cetus Corporation in 1983 and made practical by the discovery that Taq polymerase survives the heat, it now underlies most DNA-based diagnosis and identification. Mullis's Nobel-winning chemistry is separate from, and unaffected by, the unfounded claims he later made about HIV, AIDS and climate science.

Chapters & takeaways6
  1. 0:08
    Heat, cool, copy, repeat

    PCR amplifies a target DNA sequence by cycling through denaturation, annealing and extension, doubling the DNA with each round.

  2. 2:10
    A drive up the coast and a lab in Emeryville

    Mullis conceived the method in 1983 while at Cetus Corporation, and it went from sceptical colleagues to a working demonstration within the same year.

  3. 4:20
    The enzyme from a hot spring

    Swapping in heat-stable Taq polymerase from Thermus aquaticus removed the need to add fresh enzyme after every cycle, making the reaction automatable.

  4. 6:30
    What amplification can't tell you on its own

    PCR needs prior knowledge of the target sequence to design primers, and it copies contamination as readily as it copies the intended sample.

  5. 8:40
    One method, a thousand diagnoses

    From prenatal screening to pathogen detection to forensic identification, PCR became the shared engine behind DNA-based testing.

  6. 10:50
    The chemistry earned the prize; the later claims did not

    Judging PCR on its results and judging Mullis's unrelated later statements are two separate exercises, and only one of them belongs to the science.

Worth your time?

Yes. Study the whole thing.

5/ 5
What works
  • explains the three-step cycle plainly enough to make the exponential copying make sense
  • identifies the specific enzyme substitution, Taq polymerase, that turned a clever idea into a practical tool
  • keeps the technique's validity clearly separate from its inventor's later, unrelated public claims
What does not
  • does not dwell on the range of modern PCR variants beyond the original method
  • leaves the mechanics of primer design only briefly addressed
Study it if
  • anyone who wants to understand what a PCR test actually does
  • readers interested in how a single technique reshaped an entire field
  • people curious about the gap between a scientist's proven work and their unrelated public claims
Skip it if
  • readers wanting step-by-step laboratory protocol detail
  • anyone looking for a tidy hero narrative with no complicating footnote
The written brief3 min read

Heat, cool, copy, repeat

The claim is a practical one: that a specific stretch of DNA, however small the starting sample, can be copied into enough material to study, by cycling it through a repeating sequence of temperatures rather than growing it in a living cell. The reaction runs in three repeated steps — denaturation, which heats the sample enough to separate the two DNA strands; annealing, which cools it so that short synthetic primers bind to the target sequence; and extension, at an intermediate temperature, where an enzyme builds a new complementary strand from each template. Each full cycle roughly doubles the amount of the targeted sequence, so a typical run of twenty to forty cycles turns a handful of starting molecules into an amount large enough to detect, sequence or clone directly.

A drive up the coast and a lab in Emeryville

Kary Mullis conceived the method in 1983 while working at Cetus Corporation in Emeryville, California, reportedly working out the idea while driving near his home in Mendocino County. He demonstrated the approach successfully before the end of that year, though colleagues at Cetus were initially sceptical, and his supervisor Thomas White reassigned him to the project full-time once the potential became clear. Other scientists at Cetus, including Randall Saiki, Henry Erlich and Norman Arnheim, ran parallel work confirming the method could amplify specific genes from human DNA, publishing a paper on amplifying the beta-globin gene in Science in 1985 that later received its own recognition as a landmark in the field.

The enzyme from a hot spring

What made the technique genuinely practical, rather than merely clever, was a substitution made in 1986: replacing the original DNA polymerase, which the heat of each denaturation step destroyed and which therefore had to be manually replenished after every cycle, with Taq polymerase, an enzyme drawn from Thermus aquaticus, a bacterium that lives naturally in hot springs at temperatures between roughly 50 and 80 degrees Celsius. Because Taq polymerase tolerates the heat that PCR’s denaturation step requires, the whole cycle could run automatically in a single machine without intervention, which is what turned the reaction from a laboratory demonstration into a routine, scalable tool. Mullis and Michael Smith shared the 1993 Nobel Prize in Chemistry for the DNA manipulation work that PCR represented.

What amplification can’t tell you on its own

The method has clear preconditions and failure modes. Designing the short primers that bracket the target sequence requires already knowing enough about that sequence to write them, so PCR cannot amplify a completely unknown stretch of DNA out of nothing. Because the reaction copies whatever template DNA is present with tremendous efficiency, even minute amounts of contaminating DNA can be amplified alongside, or instead of, the intended sample, producing misleading results if laboratory technique is not rigorous. The polymerase used also introduces occasional copying errors, and inhibitory substances present in some real-world samples, such as humic acids in environmental material, can suppress the reaction outright.

One method, a thousand diagnoses

The reach of the technique beyond the original research laboratory is broad and well established. In medicine it underlies prenatal testing, carrier screening for inherited conditions, and detection of cancer-associated mutations; in infectious disease it is the basis for identifying pathogens including HIV, tuberculosis, and, through its RT-PCR variant, the virus responsible for COVID-19. Forensic laboratories use it to generate DNA profiles from crime-scene material too small for older methods, and researchers use it routinely for cloning, sequencing preparation and evolutionary comparisons across species. The shared thread across all of these applications is the same basic cycle described above, adapted rather than replaced for each purpose.

The chemistry earned the prize; the later claims did not

PCR earns its place as a genuine turning point in molecular biology, and the chemistry behind it is not in dispute: the amplification works as described, the enzyme substitution that made it practical is well documented, and its diagnostic and forensic applications are in continuous, verifiable use. What deserves a separate judgement is Mullis himself, whose later public statements questioning the link between HIV and AIDS, and expressing scepticism about human-caused climate change, were not supported by research he conducted and stand apart from the chemistry that won him his prize. Reading about PCR is worth the time on the strength of the technique alone; treating Mullis’s unrelated later claims as carrying the same authority would be a mistake the material itself does not make.

Same field · Genetics4 of 60
13:00
Prime editingIn October 2019, David Liu's lab at the Broad Institute, with Andrew Anzalone and Luke Koblan as lead authors, disclosed prime editing, a genome editing method that fuses a modified Cas9 that cuts only one strand of DNA to a reverse transcriptase enzyme, guided by an extended guide RNA that both finds the target and carries the template for the replacement sequence. Rather than relying on a double-strand break and the cell's own, error-prone repair pathways, as standard CRISPR-Cas9 does, prime editing writes the new sequence directly using the nicked strand as a starting point, then lets the cell's mismatch repair machinery finish installing it. That approach can perform all twelve possible single-letter DNA changes, insertions up to 44 base pairs, and deletions up to 80 base pairs, a wider range than the earlier base editors from the same lab could manage. Successive engineered versions improved editing efficiency several-fold over the original design, and by 2024 a prime editor-based therapy called PM359 had entered clinical trials, with the company reporting in 2025 that two patients treated for chronic granulomatous disease had been effectively cured.
13:00
Zinc fingerStudying how the frog Xenopus laevis makes a transcription factor called TFIIIA, Aaron Klug's laboratory at the MRC Laboratory of Molecular Biology found that the protein needed zinc ions to work, and that its sequence repeated the same short pattern of cysteines and histidines nine times over. Modelling that repeat led Klug and colleagues to the zinc finger: a compact, zinc-stabilised loop that lets a protein grip a short stretch of DNA, with several fingers strung together to read a longer sequence. The motif turned out to be one of the most common DNA-binding shapes in the genome and later became a building block for engineered gene-editing and gene-control tools.
13:00
Recombinant DNAIn 1973 Stanley Cohen and Herbert Boyer showed that a gene cut from one organism with restriction enzymes could be inserted into a bacterial plasmid and expressed by the bacterium as its own, creating the first recombinant DNA. The technique became the foundation of the biotechnology industry, used by 1978 to produce synthetic human insulin, commercialised by Boyer's company Genentech and later licensed to Eli Lilly as the first approved recombinant drug. Before any product reached patients, scientists organised the 1975 Asilomar Conference and imposed a voluntary moratorium on the riskiest experiments, an early instance of a field regulating itself ahead of external pressure.
13:00
RNA interferenceWorking with the roundworm Caenorhabditis elegans, Andrew Fire and Craig Mello found in 1998 that injecting double-stranded RNA silenced a matching gene far more effectively than either of its single strands alone, a result that pointed to an unrecognised natural pathway rather than a chemical curiosity. That pathway, RNA interference, works by chopping double-stranded RNA into short fragments that guide a protein complex to destroy or block matching messenger RNA, and it shares components with a related but distinct natural pathway built around microRNAs, discovered separately in the same worm by Victor Ambros and Gary Ruvkun. Fire and Mello shared the 2006 Nobel Prize in Physiology or Medicine, and Ambros and Ruvkun shared the 2024 prize for the microRNA work.
Up next in Science

Positron emission tomography

· 13:00

PET scanning images metabolic activity rather than anatomy, by catching the paired gamma rays a positron tracer produces on annihilation — a physical trick that took decades, and Michel Ter-Pogossian's team, to turn into a working scanner.

13:00